Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer-Reference-Cited by-同舟云学术

Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer

Published:2018-02-23 Issue:7 Volume:45 Page:1205-1217
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Chen Bang-Bin,Tien Yu-Wen,Chang Ming-Chu,Cheng Mei-Fang,Chang Yu-Ting,Yang Shih-Hung,Wu Chih-Horng,Kuo Ting-Chun,Shih I-Lun,Yen Ruoh-Fang,Shih Tiffany Ting-Fang

Funder

National Taiwan University Hospital, Taipei, Taiwan

Ministry of Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-018-3960-0/fulltext.html

Reference36 articles.

1. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371:2140–1. https://doi.org/10.1056/NEJMc1412266 .

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30. https://doi.org/10.3322/caac.21387 .

3. O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14:169–86. https://doi.org/10.1038/nrclinonc.2016.162 .

4. Rosenkrantz AB, Friedman K, Chandarana H, Melsaether A, Moy L, Ding YS, et al. Current status of hybrid PET/MRI in oncologic imaging. AJR Am J Roentgenol. 2016;206:162–72. https://doi.org/10.2214/AJR.15.14968 .

5. Torigian DA, Zaidi H, Kwee TC, Saboury B, Udupa JK, Cho ZH, et al. PET/MR imaging: technical aspects and potential clinical applications. Radiology. 2013;267:26–44. https://doi.org/10.1148/radiol.13121038 .

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limited Role of the Apparent Diffusion Coefficient (ADC) for Tumor Grade and Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma;Diagnostics;2024-03-07

2. Baseline Characteristics and Use of Pretherapeutic 18F-Fluorodeoxyglucose-PET for Pancreatic Cancer;Journal of the American College of Surgeons;2024-03-06

3. Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer;Cancer Imaging;2024-02-26

4. The Role of PET in Diagnosis of Pancreatic Cancer and Cancer Recurrence;The Pancreas;2023-08-04

5. PET/MRI for evaluation of patients with pancreatic cancer;Abdominal Radiology;2023-05-16